WILMINGTON, Del., Aug. 15, 2017 -- Rigrodsky & Long, P.A.:
Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Massachusetts on behalf of holders of PAREXEL International Corporation (“PAREXEL”) (NasdaqGS:PRXL) common stock in connection with the proposed acquisition of PAREXEL by affiliates of Pamplona Capital Management (“Pamplona”) announced on June 20, 2017 (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against PAREXEL, its Board of Directors (the “Board”), and Pamplona, is captioned Scarantino v. PAREXEL International Corporation, Case No. 17-cv-11360 (D. Mass.).
If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242, by e-mail at [email protected], or at http://rigrodskylong.com/contact-us/.
On June 19, 2017, PAREXEL entered into an agreement and plan of merger (the “Merger Agreement”) with Pamplona. Pursuant to the Merger Agreement, shareholders of PAREXEL will receive $88.10 in cash for each share of PAREXEL stock they own (the “Proposed Transaction”).
Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, defendants issued materially incomplete disclosures in a proxy statement (the “Proxy Statement”) filed with the United States Securities and Exchange Commission on July 14, 2017. The Complaint alleges that the Proxy Statement, which recommends that PAREXEL stockholders vote in favor of the Proposed Transaction, omits material information necessary to enable shareholders to make an informed decision as to how to vote on the Proposed Transaction, including material information with respect to PAREXEL’s financial projections, the analyses performed by PAREXEL’s financial advisor, and potential conflicts of interest. The Complaint seeks injunctive and equitable relief and damages on behalf of holders of PAREXEL common stock.
If you wish to serve as lead plaintiff, you must move the Court no later than October 13, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities fraud, shareholder corporate, and shareholder derivative litigation on behalf of shareholders in state and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (302) 295-5310 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com


Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
OpenAI Explores Massive Funding Round at $750 Billion Valuation
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



